Sample requirements |
Plasma volume |
500 ul |
Depends on method used for extraction |
Viral load |
>2,000 RNA copies/ml is recommended |
>1,000 RNA copies/ml is recommended |
RNA isolation |
|
Lysis and centrifugation using a modification of the MONITOR Ultrasensitive Method (Roche Diagnostics). |
Separate kits can be purchased for RNA extraction. |
RT/PCR |
RT |
Single primer, MMuLV RT, RNase inhibitor |
Single primer, MMuLV RT, RNase inhibitor |
PCR |
Non-nested, 40 cycles with Ampli- Taq Gold DNA polymerase. 1.8 kb product |
Non-nested, 27 cycles with proprietary DNA polymerase. 1.3 kb product |
Controls |
Positive and negative controls included beginning with the RT/PCR step. dUTP/UNG Amperase |
Positive and negative controls included beginning with the RT/PCR step. |
Sample clean up |
Microcon columns |
None |
Analysis |
Agarose gel |
None |
Equipment needed |
9600 or 9700 thermal cycler |
Laboratory’s preferred thermal cycler |
Sequencing |
Method |
BigDye™ dideoxyterminators |
CLIP bi-directional |
Number of primers |
6–7 primers, one per reaction |
6 reactions, each containing a primer mix |
Equipment |
9600 or 9700 thermal cycler, ABI 310, 377, 3100 |
Customized equipment for gel preparation and electrophoresis |
Throughput |
16 samples per 7 hour run on ABI 377 (96-well). 32 samples per run over 24 hours on ABI 3100 |
1 sample per 50 minute run. With 4 Long Read Towers, 28 samples in 8 hours |
Data analysis system |
Region analyzed |
Protease 1-99, RT 1-320 |
Protease 1-99, RT 40-247 |
Computer platform |
MacIntosh for ABI 377/ABI 310, PC or MacIntosh for ABI3100 |
PC |
Software features |
Primer assembly, auto trimming, full view of electropherograms, translation and alignment to reference sequence, quick tab to positions of interest for editing. |
Primer assembly, auto trimming, full view of electropherograms, translation and alignment to reference sequence, quicktab to positions of interest for editing. Includes “fingerprinting” comparison to prior runs. |
Mutations reported |
Resistance mutations, novel variants, insertions/deletions |
Resistance mutations, known polymorphisms, novel variants, insertions/deletions |
Sequence format |
FASTA |
FASTA (Ns may need to be deleted for data analysis) |
Other reported information |
Information about sequence quality and editing |
Drug resistance interpretation |